rxstat › Shortages › Labetalol

Labetalol shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Labetalol is in a widespread shortage in Canada. 4 of 8 reported products are affected. The latest manufacturer estimate for full recovery is May 8, 2026.
Products affected
4 / 8
In shortage since
Nov 8, 2024
Est. full return
May 8, 2026
Reports on file
38
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
LABETALOL HYDROCHLORIDE INJECTION
5MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02457040 · since May 13, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-LABETALOL
200MG · TABLET · APOTEX INC
DIN 02243539 · since Mar 31, 2026, est. end May 8, 2026 · Disruption of the manufacture of the drug.
Active shortage
TRANDATE
200MG · TABLET · PALADIN PHARMA INC.
DIN 02106280 · since Nov 8, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TRANDATE
100MG · TABLET · PALADIN PHARMA INC.
DIN 02106272 · since Nov 8, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
LABETALOL HYDROCHLORIDE INJECTION USP
5MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02231689 · ended Jun 30, 2025 · Demand increase for the drug.
Resolved
LABETALOL HYDROCHLORIDE INJECTION USP
5MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02231689 · ended Mar 31, 2025 · Disruption of the manufacture of the drug.
Resolved
LABETALOL HYDROCHLORIDE INJECTION USP
5MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02231689 · ended Feb 10, 2025 · Demand increase for the drug.
Discontinued
LABETALOL HYDROCHLORIDE INJECTION, USP
5MG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02387468
Resolved
LABETALOL HYDROCHLORIDE INJECTION, USP
5MG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02387468 · ended Jan 10, 2023 · Demand increase for the drug.
Resolved
APO-LABETALOL
200MG · TABLET · APOTEX INC
DIN 02243539 · ended Nov 28, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-LABETALOL
100MG · TABLET · APOTEX INC
DIN 02243538 · ended Oct 24, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-LABETALOL
200MG · TABLET · APOTEX INC
DIN 02243539 · ended Jun 27, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 38 reports. All reports are on file with Health Canada.

What's happening

Labetalol is currently affected by 4 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED, APOTEX INC, PALADIN PHARMA INC..

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Labetalol is classified under “BETA BLOCKING AGENTS” (ATC C07AG).

Recent changes

Common questions

When will Labetalol be back in stock in Canada?

The latest manufacturer estimate is May 8, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Labetalol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (beta blocking agents)

Widespread shortageNadolol2 of 2 reported products affected · est. return Jun 26, 2026Partial shortageAcebutolol2 of 21 reported products affectedPartial shortageAtenolol7 of 34 reported products affectedPartial shortageCarvedilol8 of 30 reported products affected · est. return Jul 24, 2026Partial shortageMetoprolol4 of 37 reported products affected · est. return Dec 31, 2026Partial shortagePindolol2 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.